Charlson comorbidity index: a critical review of clinimetric properties
ME Charlson, D Carrozzino, J Guidi… - Psychotherapy and …, 2022 - karger.com
The present critical review was conducted to evaluate the clinimetric properties of the
Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long …
Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long …
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade… - Blood, The Journal …, 2017 - ashpublications.org
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for
diagnosis and management of acute myeloid leukemia (AML) in adults are widely …
diagnosis and management of acute myeloid leukemia (AML) in adults are widely …
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
J Dehn, S Spellman, CK Hurley… - Blood, The Journal …, 2019 - ashpublications.org
Allogeneic hematopoietic cell transplantation involves consideration of both donor and
recipient characteristics to guide the selection of a suitable graft. Sufficient high-resolution …
recipient characteristics to guide the selection of a suitable graft. Sufficient high-resolution …
Acute myeloid leukemia
H Döhner, DJ Weisdorf… - New England Journal of …, 2015 - Mass Medical Soc
Acute Myeloid Leukemia | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
T De Witte, D Bowen, M Robin… - Blood, The Journal …, 2017 - ashpublications.org
An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Acute myeloid leukaemia
Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …
Transplantation regularly publishes on the current practice and indications for …
Hematopoietic stem cell transplantation for patients with AML in first complete remission
JJ Cornelissen, D Blaise - Blood, The Journal of the American …, 2016 - ashpublications.org
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
Intestinal microbiota and relapse after hematopoietic-cell transplantation
Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …